Fluoropharma Medical, Inc. (PN) Stock Price - FPMI

0.00 (0.0%)
Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Ultimate Trader (Monthly)
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Fluoropharma Medical, Inc. (PN) FPMI OTC BB Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.00 0.0% 0.0028 0.00 0.00 0.00 0.0028 16:21:06
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.0028 USD

Fluoropharma Medical, Inc. (PN) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 96.57k 34.49M $ -5.61M - - 21.76M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Fluoropharma Medical, Inc. (PN) News

Loading Messages....

Latest FPMI Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical FPMI Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.00250.0050.00250.003994913,1330.000312.0%
1 Month0.00220.0050.00220.004039111,5500.000627.27%
3 Months0.00410.0070.00210.003544352,036-0.0013-31.71%
6 Months0.01110.0180.00110.003328364,420-0.0083-74.77%
1 Year0.100.100.00110.013860855,379-0.0972-97.2%
3 Years0.0710.250.00110.052654543,626-0.0682-96.06%
5 Years0.460.4990.00110.154462943,155-0.4572-99.39%

Fluoropharma Medical, Inc. (PN) Description

We are a molecular imaging company headquartered in Montclair, NJ. The Company was founded to engage in the discovery, development and commercialization of proprietary products for the positron emission tomography (PET) market. The Company's initial focus has been on the development of novel cardiovascular imaging agents that can more efficiently and effectively detect and assess acute and chronic forms of coronary artery disease (CAD). Molecular imaging pharmaceuticals are radiopharmaceuticals that enable early detection of disease through the visualization of subtle changes in biochemical and biological processes.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.